Darwin Wealth Management’s Elevance Health ELV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
Hold
0
610
2025
Q2
Sell
-10
Closed -$3.69K 634
2025
Q1
$3.69K Hold
10
﹤0.01% 465
2024
Q4
$3.69K Hold
10
﹤0.01% 465
2024
Q3
$5.2K Buy
+10
New +$5.34K ﹤0.01% 455
2020
Q2
Sell
-381
Closed -$86K 316
2020
Q1
$86K Buy
+381
New +$104K 0.03% 188

Other funds holding ELV

Darwin Wealth Management's ELV Position: Q2 2026 in Review

Darwin Wealth Management held its Elevance Health (ELV) position steady in Q2 2026 at 0 shares worth $305. The position accounts for ﹤0.01% of the portfolio, ranked #610.

Darwin Wealth Management first reported a position in ELV in Q1 2020 and has held it in 4 quarters since. The position peaked at $86K in Q1 2020. 417 funds tracked by Wall St. Rank hold ELV as of Q2 2026.

  • Darwin Wealth Management held 0 shares of Elevance Health worth $305 as of Q2 2026.
  • Darwin Wealth Management left its Elevance Health share count unchanged in Q2 2026.
  • Elevance Health made up ﹤0.01% of Darwin Wealth Management's portfolio in Q2 2026, its #610 holding.
  • Darwin Wealth Management first reported a position in Elevance Health in Q1 2020 and has held it in 4 quarters since.
  • Darwin Wealth Management's Elevance Health position peaked at $86K in Q1 2020.
  • 417 funds tracked by Wall St. Rank held Elevance Health as of Q2 2026.

Based on Darwin Wealth Management's 13F filing for Q2 2026, filed 21 Jul 2026.